Production of medical radioisotopes at the Belgian nuclear research centre SCK CEN’s BR2 research reactor met the needs of 13 million patients in 2025, a new record.
SCK CEN said it had increased the number of operating days from 160 to 210 a year in 2020. This led to a record during of 12 million patients who received diagnosis or treatment thanks to that production. This was five million more than the previous average.
By 2025, 13 million patients were relying on BR2’s production for diagnosis or treatment, SCK CEN said.
Want to keep reading?
Register free and get full access to NucNet for 14 days. No card required.
- Daily news briefing on the global nuclear industry
- Weekly, monthly and topical newsletters
- 24/7 coverage during nuclear incidents and safety events
- Full searchable archive, 30,000+ articles since 1991
- SMR and AMR project database
- Analysis, Focus pieces and infographics
- NucNet Style Guide for nuclear reporters and communicators
After the trial, keep a free account for a newsletter and a complimentary Plus article every two weeks. Or see our subscription plans for individuals and organisations.
See subscription options